Head and neck cancer Trials in Nijmegen, Netherlands
Conditions / Head and neck cancer / Nijmegen, Netherlands
Clinical trials for Head and neck cancer investigate a range of treatment strategies and patient populations.
20 total trials for this combination
Showing top 10 of 20 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT00003888 | Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced Head and Neck Cancer | COMPLETED | PHASE3 |
| NCT00022594 | Liposomal Lurtotecan in Treating Patients With Metastatic or Locally Recurrent Head and Neck Cancer | COMPLETED | PHASE2 |
| NCT04075305 | The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study | RECRUITING | — |
| NCT00098943 | NGR-TNF in Treating Patients With Advanced Solid Tumors | COMPLETED | PHASE1 |
| NCT02903914 | Arginase Inhibitor INCB001158 as a Single Agent and in Combination With Immune Checkpoint Therapy in Patients With Advanced/Metastatic Solid Tumors | COMPLETED | PHASE1 |
| NCT03170960 | Study of Cabozantinib Alone or in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors | ACTIVE_NOT_RECRUITING | PHASE1 |
| NCT00002555 | High-Dose Radiation Therapy With or Without Chemotherapy in Treating Patients With Head and Neck Cancer | COMPLETED | PHASE3 |
| NCT06172478 | A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors | RECRUITING | PHASE2 |
| NCT00122460 | Cetuximab (Erbitux) in Combination With Cisplatin or Carboplatin and 5-Fluorouracil in the First Line Treatment of Subjects With Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck (EXTREME) | COMPLETED | PHASE3 |
| NCT01046266 | A Study of Pharmacodynamics of RO5083945 in Patients With Head and Neck Squamous Cell Carcinoma | COMPLETED | PHASE1 |